Agency Information Collection Activities: Submission for OMB Review; Comment Request, 506-507 [2019-28477]
Download as PDF
<![CDATA[
506
Federal Register / Vol. 85, No. 3 / Monday, January 6, 2020 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2019–28450 Filed 1–3–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Healthcare Infection Control
Practices Advisory Committee
(HICPAC). This meeting is open to the
public, limited only by the space
available. The meeting room
accommodates up to 120 people. The
public is also welcome to listen to the
meeting via teleconference at 1–800–
857–2850, passcode: 2622054; 100
teleconference lines are available.
DATES: The meeting will be held on
March 5, 2020, 9:00 a.m. to 5:00 p.m.,
EST, and March 6, 2020, 9:00 a.m. to
12:00 p.m., EST.
ADDRESSES: Centers for Disease Control
and Prevention, Global Communications
Center, Building 19, Auditorium B, 1600
Clifton Road NE, Atlanta, Georgia
30329–4027 and teleconference at 1–
800–857–2850, passcode: 2622054.
FOR FURTHER INFORMATION CONTACT: KooWhang Chung, M.P.H., HICPAC,
Division of Healthcare Quality
Promotion, NCEZID, CDC, l600 Clifton
Road NE, Mailstop H16–3, Atlanta,
Georgia 30329–4027; Telephone: (404)
498–0730; Email: hicpac@cdc.gov.
SUPPLEMENTARY INFORMATION: Time will
be available for public comment. The
public is welcome to submit written
comments in advance of the meeting.
Comments should be submitted in
writing by email to the contact person
listed below. The deadline for receipt of
written public comment is February 20,
2020. All requests must contain the
name, address, and organizational
affiliation of the speaker, as well as the
topic being addressed. Written
comments should not exceed one singlespaced typed page in length and
lotter on DSKBCFDHB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:53 Jan 03, 2020
Jkt 250001
delivered in 3 minutes or less. Members
of the public who wish to provide
public comments should plan to attend
the public comment session at the start
time listed. Please note that the public
comment period may end before the
time indicated, following the last call
for comments. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. Registration is required to
attend in person or on the phone.
Interested parties must be processed in
accordance with established federal
policies and procedures and may
register at https://www.cdc.gov/hicpac.
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion (DHQP), the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, and the Secretary,
Health and Human Services, regarding
(1) the practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters To Be Considered: The agenda
will include updates on CDC’s activities
for prevention of healthcare-associated
infections. It will also include updates
from the following HICPAC workgroups:
The Healthcare Personnel Guideline
Workgroup; the Neonatal Intensive Care
Unit (NICU) Guideline Workgroup; the
National Healthcare Safety Network
(NHSN) Workgroup; and the
Bloodstream Infection Workgroup. The
agenda also includes updates on CDC
and DHQP activities. Agenda items are
subject to change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2019–28449 Filed 1–3–20; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00014
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10237]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
SUMMARY:
Comments on the collection(s) of
information must be received by the
OMB desk officer by February 5, 2020.
ADDRESSES: When commenting on the
proposed information collections,
please reference the document identifier
or OMB control number. To be assured
consideration, comments and
recommendations must be received by
the OMB desk officer via one of the
following transmissions: OMB, Office of
Information and Regulatory Affairs,
Attention: CMS Desk Officer, Fax
Number: (202) 395–5806 OR Email:
OIRA_submission@omb.eop.gov.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/
PRA=Listing.html.
DATES:
E:\FR\FM\06JAN1.SGM
06JAN1
lotter on DSKBCFDHB2PROD with NOTICES
Federal Register / Vol. 85, No. 3 / Monday, January 6, 2020 / Notices
1. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
2. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: Revision with change of a
currently approved; Title of Information
Collection: Applications for Part C
Medicare Advantage, 1876 Cost Plans,
and Employer Group Waiver Plans to
Provide Part C Benefits; Use: This
information collection includes the
process for organizations wishing to
provide healthcare services under MA
plans. These organizations must
complete an application annually (if
required), file a bid, and receive final
approval from CMS. The MA
application process has two options for
applicants that include (1) request for
new MA product or (2) request for
expanding the service area of an existing
product. CMS utilizes the application
process as the means to review, assess
and determine if applicants are
compliant with the current
requirements for participation in the
MA program and to make a decision
related to contract award. This
collection process is the only
mechanism for organizations to
complete the required MA application
process. The application process is open
to all health plans that want to
participate in the MA program. The
application is distinct and separate from
the bid process, and CMS issues a
determination on the application prior
VerDate Sep<11>2014
17:53 Jan 03, 2020
Jkt 250001
to bid submissions, or before the first
Monday in June.
Collection of this information is
mandated by the Code of Federal
Regulations, MMA, and CMS
regulations at 42 CFR 422, subpart K, in
‘‘Application Procedures and Contracts
for Medicare Advantage Organizations.’’
In addition, the Medicare Improvement
for Patients and Providers Act of 2008
(MIPPA) further amended titles XVII
and XIX of the Social Security Act.
Form Number: CMS–10237 (OMB
control number: 0938–0935); Frequency:
Occasionally; Affected Public: Private
Sector (Business or other for-profit and
Not-for-profit institutions); Number of
Respondents: 435; Total Annual
Responses: 435; Total Annual Hours:
6,754. (For policy questions regarding
this collection contact Keith Penn-Jones
at 410–786–3104.)
Dated: December 31, 2019.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2019–28477 Filed 1–3–20; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2019–N–0001]
Vaccines and Related Biological
Products Advisory Committee; Notice
of Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or Agency)
announces a forthcoming public
advisory committee meeting of the
Vaccines and Related Biological
Products Advisory Committee
(VRBPAC). The general function of the
committee is to provide advice and
recommendations to the Agency on
FDA’s regulatory issues. At least one
portion of the meeting will be closed to
the public.
DATES: The meeting will be held on
March 4, 2020, from 8:30 a.m. to 5:10
p.m.
SUMMARY:
FDA White Oak Campus,
10903 New Hampshire Ave., Bldg. 31
Conference Center, the Great Room (Rm.
1503), Silver Spring, MD 20993–0002.
For those unable to attend in person, the
meeting will also be webcast and will be
available at the following link: https://
collaboration.fda.gov/vrbpac030420/.
ADDRESSES:
PO 00000
Frm 00015
Fmt 4703
Sfmt 4703
507
Answers to commonly asked questions
including information regarding special
accommodations due to a disability,
visitor parking, and transportation may
be accessed at: https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm408555.htm.
FOR FURTHER INFORMATION CONTACT:
Kathleen Hayes or Monique Hill, Center
for Biologics Evaluation and Research,
Food and Drug Administration, 10903
New Hampshire Ave., Bldg. 71, Rm.
6307C, Silver Spring, MD 20993–0002,
301–796–7864, Kathleen.Hayes@
fda.hhs.gov, or 301–796–4620,
monique.hill@fda.hhs.gov, respectively;
or the FDA Advisory Committee
Information Line, 1–800–741–8138
(301–443–0572 in the Washington, DC
area). A notice in the Federal Register
about last minute modifications that
impact a previously announced
advisory committee meeting cannot
always be published quickly enough to
provide timely notice. Therefore, you
should always check the Agency’s
website at https://www.fda.gov/
AdvisoryCommittees/default.htm and
scroll down to the appropriate advisory
committee meeting link, or call the
advisory committee information line to
learn about possible modifications
before coming to the meeting.
SUPPLEMENTARY INFORMATION:
Agenda: On March 4, 2020, under
Topic I, the Center for Biologics
Evaluation and Research’s (CBER)
VRBPAC will meet in open session to
discuss and make recommendations on
the selection of strains to be included in
the influenza virus vaccines for the 2020
to 2021 influenza season. Also, on
March 4, 2020, under Topic II, the
committee will meet in open session to
hear an overview of the research
programs in the Laboratory of
Respiratory and Special Pathogens
(LRSP), Division of Bacterial, Parasitic,
and Allergenic Products, Office of
Vaccines Research and Review, CBER.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its website prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s website after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee meeting
link.
E:\FR\FM\06JAN1.SGM
06JAN1
]]>Agencies
[Federal Register Volume 85, Number 3 (Monday, January 6, 2020)]
[Notices]
[Pages 506-507]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-28477]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier: CMS-10237]
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
AGENCY: Centers for Medicare & Medicaid Services, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (PRA), federal agencies are required to publish notice in
the Federal Register concerning each proposed collection of
information, including each proposed extension or reinstatement of an
existing collection of information, and to allow a second opportunity
for public comment on the notice. Interested persons are invited to
send comments regarding the burden estimate or any other aspect of this
collection of information, including the necessity and utility of the
proposed information collection for the proper performance of the
agency's functions, the accuracy of the estimated burden, ways to
enhance the quality, utility, and clarity of the information to be
collected, and the use of automated collection techniques or other
forms of information technology to minimize the information collection
burden.
DATES: Comments on the collection(s) of information must be received by
the OMB desk officer by February 5, 2020.
ADDRESSES: When commenting on the proposed information collections,
please reference the document identifier or OMB control number. To be
assured consideration, comments and recommendations must be received by
the OMB desk officer via one of the following transmissions: OMB,
Office of Information and Regulatory Affairs, Attention: CMS Desk
Officer, Fax Number: (202) 395-5806 OR Email:
[email protected].
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, you may make
your request using one of following:
1. Access CMS' website address at website address at https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA=Listing.html.
[[Page 507]]
1. Email your request, including your address, phone number, OMB
number, and CMS document identifier, to [email protected].
2. Call the Reports Clearance Office at (410) 786-1326.
FOR FURTHER INFORMATION CONTACT: William Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. The term ``collection of
information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and
includes agency requests or requirements that members of the public
submit reports, keep records, or provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires
federal agencies to publish a 30-day notice in the Federal Register
concerning each proposed collection of information, including each
proposed extension or reinstatement of an existing collection of
information, before submitting the collection to OMB for approval. To
comply with this requirement, CMS is publishing this notice that
summarizes the following proposed collection(s) of information for
public comment:
1. Type of Information Collection Request: Revision with change of
a currently approved; Title of Information Collection: Applications for
Part C Medicare Advantage, 1876 Cost Plans, and Employer Group Waiver
Plans to Provide Part C Benefits; Use: This information collection
includes the process for organizations wishing to provide healthcare
services under MA plans. These organizations must complete an
application annually (if required), file a bid, and receive final
approval from CMS. The MA application process has two options for
applicants that include (1) request for new MA product or (2) request
for expanding the service area of an existing product. CMS utilizes the
application process as the means to review, assess and determine if
applicants are compliant with the current requirements for
participation in the MA program and to make a decision related to
contract award. This collection process is the only mechanism for
organizations to complete the required MA application process. The
application process is open to all health plans that want to
participate in the MA program. The application is distinct and separate
from the bid process, and CMS issues a determination on the application
prior to bid submissions, or before the first Monday in June.
Collection of this information is mandated by the Code of Federal
Regulations, MMA, and CMS regulations at 42 CFR 422, subpart K, in
``Application Procedures and Contracts for Medicare Advantage
Organizations.'' In addition, the Medicare Improvement for Patients and
Providers Act of 2008 (MIPPA) further amended titles XVII and XIX of
the Social Security Act. Form Number: CMS-10237 (OMB control number:
0938-0935); Frequency: Occasionally; Affected Public: Private Sector
(Business or other for-profit and Not-for-profit institutions); Number
of Respondents: 435; Total Annual Responses: 435; Total Annual Hours:
6,754. (For policy questions regarding this collection contact Keith
Penn-Jones at 410-786-3104.)
Dated: December 31, 2019.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2019-28477 Filed 1-3-20; 8:45 am]
BILLING CODE 4120-01-P
